Tennessee · 114th Regular Session (2025-2026) · Bill

SB 422: Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

In committee Last action April 20, 2026: Assigned to General Subcommittee of Senate Finance, Ways, and Means Committee

Plain-language summary

SB 422 is a bill introduced in the Tennessee Senate on January 28, 2025. According to its official title, it concerns: Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71. Primary sponsor: Reeves. Most recent recorded action (April 20, 2026): Assigned to General Subcommittee of Senate Finance, Ways, and Means Committee.

Sponsors

Primary sponsor: Reeves.